Furthermore, IGF-IR is more strongly expressed in advanced subtypes of MDS, such as refractory anemia with excess progenitor cells and its transformed form (158), which are associated with an increased proportion of blasts in the bone marrow—a critical marker indicating a heightened risk of progression from MDS to AML. The gene discussed is IGF1R; the disease is acute myeloid leukemia.